Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiangxuan Anshen Fang is a Traditional Chinese Medicine (TCM) herbal prescription developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine for the treatment of generalized anxiety disorder (GAD) and comorbid insomnia. The formula is designed based on TCM principles to soothe the liver, regulate Qi, and calm the spirit (Anshen). It typically features *Hemerocallis citrina* (Xuan Cao or Daylily), known in Chinese folklore as the "worry-forgetting herb," as a primary component alongside other herbs such as *Cyperus rotundus* (Xiang Fu). Clinical evaluation, including trial ChiCTR2200065892, focuses on its efficacy in reducing anxiety symptoms and improving sleep quality as measured by the Hamilton Anxiety Rating Scale (HAMA) and the Pittsburgh Sleep Quality Index (PSQI).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiangxuan Anshen Fang.